Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial

Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial
Introduction Metabolic surgery is the most effective known treatment option for people with severe obesity, leading to marked sustained weight loss, improvement or remission of obesity-associated comorbidities, improved quality of life, and reduced all-cause mortality. 1-3 While on a population level metabolic surgery is highly effective, on an individual level the response is highly variable.


